Presenter: R. Singh Affiliation: The University of Chicago Hospital, Chicago, IL
Among elderly women with early-stage breast cancer, age has a strong influence on treatment patterns, and many elderly women are not offered the full range of options. This is partly due to a long-held perception that breast cancer in elderly women is less aggressive as it is in younger women. In this study, the researchers assessed virulence or metastagenicity of women with breast cancer in different age groups.
Materials and Methods:
A total of 1430 patients (aged 41-91) treated with mastectomy between 1927 and 1987 were reviewed.
182 women were older than 70 years old.
Median follow-up was 12.3 years.
In women with node-negative breast cancer, there
was a significantly lower distant disease-free
survival (DDFS) in patients 40-70 compared to
those >70 (p=0.018).
For patients with node-positive disease,
significant difference in DDFS was not seen
between two age groups (p=0.2).
Virulence of the disease was similar across
Metastagenicity was slightly higher in node-
negative patients >70 (0.35 vs. 0.2).
Breast cancer did not appeared to be more indolent in women >70 years.
The treatment of breast cancer in elderly women
should not be approached differently simply based
on their age.
Further research and training are needed to
provide care for the growing population of older
women that is both clinically appropriate and
consonant with a woman's preferences.
Aug 15, 2011 - In elderly women with breast cancer and a history of cardiac disease or diabetes, treatment with trastuzumab is associated with an increased risk of cardiotoxicity, according to a study published online Aug. 9 in the Annals of Oncology.